Feasibility and Efficacy of a Digital Neurotherapy Protocol for Management of Depression, Cognition, and Quality of Life in Cancer Survivors

NCT04961047 | Completed DMC

• 2 other identifiers: 20000317152000030524
• Study Type: interventional
• Target: 36
• Locations: 1 country
• Sites: 1

Brief Summary

This is a prospective, randomized clinical study to evaluate the feasibility and efficacy of a digital neurotherapy on depression, cognition, and quality of life in two groups of patients with major medical illness: 1) a sample of cancer survivors, and 2) a sample of patients with end stage kidney disease (ESKD) on dialysis.

Conditions

Depression; Cognition; Quality of Life

Keywords

Cancer Survivor

Outcome Measures

Primary Outcomes (11)

• Change in Hospital Anxiety and Depression Questionnaire

  Hospital Anxiety and Depression Questionnaire (HADS): This survey consists of 14 questions. The questions are related to the frequency of symptoms of anxiety and depression over the last week. Items are rated on a 0-3 scale, with several reverse-scored items. Scores range from 0 to 21. Higher scores indicate more severe symptoms. Administration time is 5 minutes.

  Baseline, 4 weeks, 8 weeks

• Change in Patient Health Questionnaire-9

  Patient Health Questionnaire-9: (PHQ-9): This survey consists of 9 questions. The questions assess frequency of depression symptoms over the last two weeks. Items are rated on a 0-3 scale. Scores range from 0-27. Higher scores indicate more severe symptoms. Administration time is 5 minutes.

  Baseline, 4 weeks, 8 weeks

• Change in Functional Assessment of Cancer Therapy-General

  Functional Assessment of Cancer Therapy-General (FACT-G): The FACT-G is a 27-item questionnaire designed to measure four domains of health related quality of life in cancer patients: Physical, social, emotional, and functional well-being. Respondents are asked to answer in reference to the last 7 days. Items are on a 5 point Likert-type scale. Scores range from 0-108 with higher scores indicating higher quality of life. Administration time is 5-10 minutes.

  Baseline, 4 weeks, 8 weeks

• Change in Short-Form 36 Health Survey

  Functional Assessment of Cancer Therapy-General

  Baseline, 4 weeks, 8 weeks

• Change in Mindful Attention Awareness Scale

  Mindful Attention Awareness Scale (MAAS): The trait MAAS is a 15-item scale designed to assess a core characteristic of mindfulness, namely, a receptive state of mind in which attention, informed by a sensitive awareness of what is occurring in the present, simply observes what is taking place. Items are on a 6 point Likert-type scale. Scores range from 15-90, with higher scores indicating higher trait mindfulness. Administration time is 5-10 minutes.

  Baseline, 4 weeks, 8 weeks

• Change in Flanker Task

  Flanker Task: The Flanker task measures the ability to inhibit nonrelevant competing responses to a nonverbal stimulus. In this task, subjects have to indicate by keyboard response the pointing direction (right or left) of the center arrow in a linear horizontal array of five arrows. On incongruent trials, the four "flanking" arrows point in the opposite direction of the central arrow. There are 29 congruent and 17 incongruent trials presented in pseudorandom order (with 1-4 congruent trials preceding each incongruent trial and one place where there are 2 incongruent in succession). The flanking arrows precede the central arrow by 100m and successive trials are triggered by subject response. Performance is measured by the number of completed trials, accuracy, and reaction times, with higher numbers indicated better overall performance. Administration time is 5 minutes.

  Baseline, 4 weeks, 8 weeks

• Change in List Sort Working Memory

  List Sort Working Memory: This test is designed to measure working memory. Subjects are shown a series of animals or household objects. They then have to click on the objects they have just seen in a grid of 16 objects in order from smallest to largest rather than the order in which they were presented. The test starts with a list of 2 objects. If the subject completes the list accurately, list length is increased by one. If they err, the same length list is repeated. Two failed attempts at the same list length ends the test. The score is the sum of correct list lengths. In part one, trials of animals and household objects alternate. In part two, animals and household objects are presented in the same trial, and subjects have to reorder the animals first and then the household objects. Administration time is 10 minutes.

  Baseline, 4 weeks, 8 weeks

• Change in Logical Memory

  Logical Memory: This test is a measure of immediate and delayed auditory memory. In this test, subjects are read two short stories and required to immediately recall details of two short passages. Subjects are then asked to recall the passages after a 20 to 30-minute delay. Initially, the two narrative stories (story A and story B) are verbally given and the examinee is required to immediately recall the stories as much as he/she can. In the delay trial, recall of the two stories is elicited after a 20 to 30-minute delay. Each correct detail was awarded with one score point. The 30 recognition questions (either yes or no) about the two stories are given subsequently to assess the recognition ability. Higher scores indicate better performance. Administration time is approximately 50 minutes including the delay.

  Baseline, 4 weeks, 8 weeks

• Change in Multidimensional Executive Function Screening Test

  Multidimensional Executive Function Screening Test: This test is a continuous performance task (CPT) with one and two streams and with one-back as well as simple target detection. Targets can be specific abstract visual patterns with systematic degree of differences between targets and foils, and target can be members of a category (e.g., hot things). In one section, there is a concurrent memory task along with the CPT. The test score is "total number of targets clicked minus 25% of the foils clicked." (i.e., total true positive responses minus ¼ of false positive responses). Administration time is 8 minutes.

  Baseline, 4 weeks, 8 weeks

• Change in Controlled Oral Word Association Test

  Controlled Oral Word Association Test (COWAT): The COWAT is an oral fluency test in which the participant is required to make verbal associations to different letters. The COWAT requires participants to name all the words that they can beginning with specific letters (most commonly F, A, and S) within one minute. The words cannot include proper names and cannot consist of previously used words with a suffix. The total of all correct words is tallied, with higher scores indicating better performance. Administration time is 3 minutes.

  Baseline, 4 weeks, 8 weeks

• Change in California Verbal Learning Test-II

  California Verbal Learning Test-II (CVLT-II): The CVLT-II is an assessment of verbal learning and memory deficits. The test consists of three lists of words including a recognition list. The first list includes 16 items from four semantic categories; the second list has the same structure, with two semantic categories being the same as in the first list. The recognition list includes 16 target items from the first list, plus distractors that share or do not share semantic or phonological membership with that list. Administration is 30 minutes of testing and 30 minutes of delay.

  Baseline, 4 weeks, 8 weeks

Study Arms (2)

Digital neurotherapy (DNT) Treatment

EXPERIMENTAL

The experimental group will have 8 weeks of DNT 4 times a week for 30 minutes in the participant's home. The computer-presented training will be done on the participants' tablets or personal computers with the Rejuvenate brain training program

Behavioral: Digital neurotherapy (DNT) Treatment

Wait list control group

ACTIVE COMPARATOR

Waiting-list control group participants will be offered 8 weeks of DNT training at the completion of the final outcome assessment.

Behavioral: Wait list control group

Interventions

Digital neurotherapy (DNT) Treatment BEHAVIORAL

The experimental group will have 8 weeks of DNT 4 times a week for 30 minutes in the participant's home. The computer-presented training will be done on the participants' tablets or personal computers with the Rejuvenate brain training program

Digital neurotherapy (DNT) Treatment

Wait list control group BEHAVIORAL

Waiting-list control group participants will be offered 8 weeks of DNT training at the completion of the final outcome assessment.

Wait list control group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Provision of signed and date informed consent form.
• Stated willingness to comply with all study procedures and availability for the durationof the study.
• Associated with Smilow Cancer Hospital with a diagnosis for cancer
• Have received chemotherapy, and/or radiation treatment, and/or immuno therapy treatment for cancer
• Able to understand and read English

You may not qualify if:

• Stage 4 cancer
• Brain cancer
• Diagnosis of serious mental illness (ie, psychosis)
• Cognitive impairment (ie, diagnosed dementia, intellectual development disorder)
• Hearing or vision insufficient to do the computer exercises.
• ESKD Group
• Associated with Yale Nephrology practice and receiving in-center hemodialysis treatment
• Have received hemodialysis for at least one month from start of outpatient dialysis and attended 10 of first 12 visits.
• Diagnosis of serious mental illness (ie, psychosis)
• Cognitive Impairment (ie, diagnosed dementia, intellectual development disorder)
• Hearing or vision insufficient to do the computer exercises

Sponsors & Collaborators

• Yale University: lead

Study Sites (1)

Yale New Haven Hospital

New Haven, Connecticut, 06512, United States

Location

MeSH Terms

Conditions

Depression

Interventions

2,6-dinitrotoluene; Therapeutics

Condition Hierarchy (Ancestors)

Behavioral Symptoms; Behavior

Study Officials

• Anushree Shirali, MD

  Yale University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 1, 2021
• First Posted: July 14, 2021
• Study Start: December 17, 2021
• Primary Completion: May 30, 2025
• Study Completion: May 31, 2025
• Last Updated: September 15, 2025

Record last verified: 2025-09

Locations

US (1)